Who is sponsoring NCT03300934?

NCT03300934 is sponsored by Centre Hospitalier du Luxembourg.

What drugs are being tested in NCT03300934?

Interventions in NCT03300934: closed loop glucose control system.

What condition does NCT03300934 study?

NCT03300934 studies Type1 Diabetes Mellitus.

Is NCT03300934 still recruiting?

NCT03300934 is currently completed. Last updated 31 July 2018.

Last reviewed 2018-07-31 · How we verify

NCT03300934: SPIDIMAN2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adolescence and Diabetes:Can an Automated Closed Loop System Improve Control ?

Completed NA Last updated 31 July 2018

What this trial tests

NA trial testing closed loop glucose control system in Type1 Diabetes Mellitus in 16 participants. Completed in 19 July 2018.

Timeline

1 July 2017

Primary endpoint
19 July 2018

19 July 2018

Quick facts

Lead sponsor	Centre Hospitalier du Luxembourg
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	16
Start date	1 July 2017
Primary completion	19 July 2018
Estimated completion	19 July 2018
Sites	1 location across Luxembourg

Drugs / interventions tested

closed loop glucose control system

Conditions studied

Type1 Diabetes Mellitus — all drugs for Type1 Diabetes Mellitus →

Sponsor

Centre Hospitalier du Luxembourg

Who can join

Adults 12 to 18, any sex, with Type1 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the use of the FD2 automated closed loop insulin administration in Adolescents with a poor metabolic control . All youth will be treated in a random order by their usual pump treatment or an Automated system and we will evaluate whether this has an impact on metabolic control and sleep

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults.
Sherr JL. · · 2018 · cited 19× · PMID 29936422 · DOI 10.2337/dci18-0003

Verify or expand the search:

Other recruiting trials for Type1 Diabetes Mellitus

Currently open trials in the same condition.

NCT03945747 — MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus · active not recruiting
NCT03369821 — EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) · recruiting
NCT03811470 — China Diabetes Registry by Metabolic Management Center · recruiting

Other Centre Hospitalier du Luxembourg trials

Trials by the same sponsor.

NCT05271305 — Pilot Study for a National Screening for Familial Hypercholesterolemia · unknown
NCT03103867 — QUality of Control and slEep in Children With diabeteS, Using New Technology · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03300934 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier du Luxembourg
Last refreshed: 31 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03300934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing